Literature DB >> 18025262

Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alpha.

Chris D Green1, Paul D Thompson, Patrick G Johnston, Mohamed K El-Tanani.   

Abstract

The estrogen receptor (ER), like other members of the nuclear receptor superfamily, possesses two separate transcriptional activation functions, AF-1 and AF-2. Although a variety of coactivators and corepressors of AF-2 have been identified, less is known of the mechanism of action of AF-1. We have used the yeast two-hybrid system to isolate a cDNA coding for a protein that binds specifically to the AF-1 region of human ERalpha. This cDNA codes for the transcription factor basal transcription factor 3 (BTF3). The specificity of the interaction between BTF3 and ERalpha has been confirmed in vivo and in vitro. Transient transfection experiments reveal that overexpression of BTF3 modulates the transcriptional response of reporter genes to ERalpha. BTF3 interacts with ERalpha that has been activated either by 17beta-estradiol (ligand-dependent activation) or by epidermal growth factor (ligand-independent activation). The effects of BTF3 on the reporter genes requires the presence of ERalpha containing an active AF-1 function. BTF3 may be a component of the mechanism by which the AF-1 function of ERalpha stimulates gene transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025262     DOI: 10.1158/1541-7786.MCR-07-0123

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  9 in total

1.  OST1-mediated BTF3L phosphorylation positively regulates CBFs during plant cold responses.

Authors:  Yanglin Ding; Yuxin Jia; Yiting Shi; Xiaoyan Zhang; Chunpeng Song; Zhizhong Gong; Shuhua Yang
Journal:  EMBO J       Date:  2018-03-05       Impact factor: 11.598

2.  Basic transcription factor 3 is involved in gastric cancer development and progression.

Authors:  Qi Liu; Jian-Ping Zhou; Bin Li; Zhong-Cheng Huang; Hong-Yu Dong; Guang-Yi Li; Ke Zhou; Shao-Lin Nie
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

3.  Tristetraprolin represses estrogen receptor α transactivation in breast cancer cells.

Authors:  Tonatiuh Barrios-García; Angeles Tecalco-Cruz; Vania Gómez-Romero; Sandra Reyes-Carmona; Iván Meneses-Morales; Alfonso León-Del-Río
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

4.  Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic origins.

Authors:  Hsiao-Wei Chen; Hsuan-Cheng Huang; Yi-Shing Lin; King-Jen Chang; Wen-Hung Kuo; Hsiao-Lin Hwa; Fon-Jou Hsieh; Hsueh-Fen Juan
Journal:  Breast Cancer (Auckl)       Date:  2008-03-25

5.  TMREC: A Database of Transcription Factor and MiRNA Regulatory Cascades in Human Diseases.

Authors:  Shuyuan Wang; Wei Li; Baofeng Lian; Xinyi Liu; Yan Zhang; Enyu Dai; Xuexin Yu; Fanlin Meng; Wei Jiang; Xia Li
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

6.  Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

Authors:  Hantao Wang; Junjie Xing; Wei Wang; Guifen Lv; Haiyan He; Yeqing Lu; Mei Sun; Haiyan Chen; Xu Li
Journal:  Front Cell Dev Biol       Date:  2021-02-11

7.  BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C.

Authors:  Yuan Zhang; Xiang Gao; Jingyan Yi; Xiaolin Sang; Zhihong Dai; Zhiwei Tao; Min Wang; Lanlin Shen; Yaxun Jia; Daqing Xie; Hailing Cheng; Zhiyu Liu; Pixu Liu
Journal:  Cell Death Dis       Date:  2021-01-05       Impact factor: 8.469

8.  Sex-dimorphic gene expression and ineffective dosage compensation of Z-linked genes in gastrulating chicken embryos.

Authors:  Shaobing O Zhang; Sachin Mathur; Gaye Hattem; Olivier Tassy; Olivier Pourquié
Journal:  BMC Genomics       Date:  2010-01-07       Impact factor: 3.969

9.  IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells.

Authors:  Mayte Guadalupe Cervantes-Badillo; Alejandro Paredes-Villa; Vania Gómez-Romero; Rafael Cervantes-Roldán; Luis E Arias-Romero; Olga Villamar-Cruz; Miroslava González-Montiel; Tonatiuh Barrios-García; Alberto J Cabrera-Quintero; Gabriel Rodríguez-Gómez; Laura Cancino-Villeda; Alejandro Zentella-Dehesa; Alfonso León-Del-Río
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-07       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.